BENDAMUSTINE : A NEW OPTION FOR RELAPSED/ REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Cerchione, C. [1 ]
Madonna, E. [1 ]
Marano, L. [1 ]
Pugliese, N. [1 ]
Avilia, S. [1 ]
Cerciello, G. [1 ]
Pane, F. [1 ]
Catalano, L. [1 ]
机构：
[1] AOU Federico II, Hematol, Naples, Italy
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1538
引用
收藏
页码：612 / 612
页数：1
相关论文
共 50 条
  • [1] Bendamustine in patients with relapsed or refractory multiple myeloma
    M Michael
    I Bruns
    E Bölke
    F Zohren
    A Czibere
    N N Safaian
    F Neumann
    R Haas
    G Kobbe
    R Fenk
    European Journal of Medical Research, 15
  • [2] MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA WITH BENDAMUSTINE
    Cerchione, C.
    Madonna, E.
    Pareto, A. E.
    Marano, L.
    Pugliese, N.
    Peluso, I.
    Seneca, E.
    Cerciello, G.
    Avilia, S.
    Basile, S.
    Pane, F.
    Catalano, L.
    HAEMATOLOGICA, 2014, 99 : 650 - 650
  • [3] BENDAMUSTINE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Michael, M.
    Bruns, I.
    Boelke, E.
    Zohren, F.
    Czibere, A.
    Safaian, N. N.
    Ncumann, F.
    Haas, R.
    Kobbe, G.
    Fenk, R.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (01) : 13 - 19
  • [4] Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
    Dharshan Sivaraj
    Michael M Green
    Yubin Kang
    Gwynn D Long
    David A Rizzieri
    Zhiguo Li
    Anderson H Garrett
    Jackie L McIntyre
    Nelson J Chao
    Cristina Gasparetto
    Blood Cancer Journal, 8
  • [5] Bendamustine therapy for advanced relapsed/refractory multiple myeloma
    Shkury, Eden
    Geva, Mika
    Avigdor, Abraham
    Nevo, Lee
    Magen, Hila
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S189 - S189
  • [6] Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma
    Sivaraj, Dharshan
    Green, Michael M.
    Kang, Yubin
    Long, Gwynn D.
    Rizzieri, David A.
    Li, Zhiguo
    Garrett, Anderson H.
    McIntyre, Jackie L.
    Chao, Nelson J.
    Gasparetto, Cristina
    BLOOD CANCER JOURNAL, 2018, 8
  • [7] Bendamustine-bortezomib-dexamethasone in relapsed/refractory multiple myeloma.
    Cerchione, Claudio
    Nappi, Davide
    Cangini, Delia
    Ronconi, Sonia
    Ceccolini, Michela
    Musuraca, Gerardo
    Martinelli, Giovanni
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] BENDAMUSTINE-BORTEZOMIB-DESAMETASONE IN THE MANAGEMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA
    Cerchione, C.
    Catalano, L.
    Pareto, A. E.
    Basile, S.
    Marano, L.
    Peluso, I.
    Simeone, L.
    Vitagliano, O.
    Palmieri, S.
    Rocco, S.
    Ferrara, F.
    Pane, F.
    HAEMATOLOGICA, 2017, 102 : 796 - 796
  • [9] Bendamustin - a novel therapeutic option in relapsed/refractory multiple myeloma
    Krieger, O.
    Machherndl-Spandl, S.
    Binder, M.
    Weltermann, A.
    Kasparu, H.
    ONKOLOGIE, 2010, 33 : 251 - 252
  • [10] Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myeloma
    Poenisch, Wolfram
    Bourgeois, Malvina
    Moll, Barbara
    Heyn, Simone
    Jaekel, Nadja
    Wagner, Ina
    Rohrberg, Robert
    Hurtz, Hans-Juergen
    Schmalfeld, Marion
    Assmann, Michael
    Edelmann, Thomas
    Mohren, Martin
    Hoffmann, Franz Albert
    Becker, Cornelia
    Schwarzer, Andreas
    Schoenfelder, Uta
    Zehrfeld, Thomas
    Hensel, Gerald
    Loeschcke, Kerstin
    Krahl, Rainer
    Al Ali, Haifa
    Niederwieser, Dietger
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (03) : 499 - 508
12345